Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Patients with Chronic Obstructive Pulmonary Disease harbour a variation of Haemophilus species.

Osman KL, Jefferies JMC, Woelk CH, Devos N, Pascal TG, Mortier MC, Devaster JM, Wilkinson TMA, Cleary DW, Clarke SC; AERIS Study Group.

Sci Rep. 2018 Oct 3;8(1):14734. doi: 10.1038/s41598-018-32973-3.

2.

The People Living with HIV STIGMASurvey UK 2015: Stigmatising experiences and dental care.

Okala S, Doughty J, Watt RG, Santella AJ, Conway DI, Crenna-Jennings W, Mbewe R, Morton J, Lut I, Thorley L, Benton L, Hibbert M, Jefferies JMC, Kunda C, Morris S, Osborne K, Patterson H, Sharp L, Valiotis G, Hudson A, Delpech V.

Br Dent J. 2018 Jul 27;225(2):143-150. doi: 10.1038/sj.bdj.2018.530. No abstract available.

PMID:
30050184
3.

Ecology and diversity in upper respiratory tract microbial population structures from a cross-sectional community swabbing study.

Coughtrie AL, Morris DE, Anderson R, Begum N, Cleary DW, Faust SN, Jefferies JM, Kraaijeveld AR, Moore MV, Mullee MA, Roderick PJ, Tuck A, Whittaker RN, Yuen HM, Doncaster CP, Clarke SC.

J Med Microbiol. 2018 Aug;67(8):1096-1108. doi: 10.1099/jmm.0.000773. Epub 2018 Jun 21.

PMID:
29927372
4.

The adhesins of non-typeable Haemophilus influenzae.

Osman KL, Jefferies JM, Woelk CH, Cleary DW, Clarke SC.

Expert Rev Anti Infect Ther. 2018 Mar;16(3):187-196. doi: 10.1080/14787210.2018.1438263. Epub 2018 Feb 21. Review.

PMID:
29415569
5.

Pre-vaccine serotype composition within a lineage signposts its serotype replacement - a carriage study over 7 years following pneumococcal conjugate vaccine use in the UK.

Gladstone RA, Devine V, Jones J, Cleary D, Jefferies JM, Bentley SD, Faust SN, Clarke SC.

Microb Genom. 2017 Jun 9;3(6):e000119. doi: 10.1099/mgen.0.000119. eCollection 2017 Jun 30.

6.

Pneumococcal conjugate vaccine implementation in middle-income countries.

Tricarico S, McNeil HC, Cleary DW, Head MG, Lim V, Yap IKS, Wie CC, Tan CS, Norazmi MN, Aziah I, Cheah ESG, Faust SN, Jefferies JMC, Roderick PJ, Moore M, Yuen HM, Newell ML, McGrath N, Doncaster CP, Kraaijeveld AR, Webb JS, Clarke SC.

Pneumonia (Nathan). 2017 Mar 25;9:6. doi: 10.1186/s41479-017-0030-5. eCollection 2017. Review.

7.

Antiseptics for burns.

Norman G, Christie J, Liu Z, Westby MJ, Jefferies JM, Hudson T, Edwards J, Mohapatra DP, Hassan IA, Dumville JC.

Cochrane Database Syst Rev. 2017 Jul 12;7:CD011821. doi: 10.1002/14651858.CD011821.pub2. Review.

8.

The rise and fall of pneumococcal serotypes carried in the PCV era.

Devine VT, Cleary DW, Jefferies JM, Anderson R, Morris DE, Tuck AC, Gladstone RA, O'Doherty G, Kuruparan P, Bentley SD, Faust SN, Clarke SC.

Vaccine. 2017 Mar 1;35(9):1293-1298. doi: 10.1016/j.vaccine.2017.01.035. Epub 2017 Feb 1.

PMID:
28161425
9.

Comparative Genomics of Carriage and Disease Isolates of Streptococcus pneumoniae Serotype 22F Reveals Lineage-Specific Divergence and Niche Adaptation.

Cleary DW, Devine VT, Jefferies JM, Webb JS, Bentley SD, Gladstone RA, Faust SN, Clarke SC.

Genome Biol Evol. 2016 Apr 21;8(4):1243-51. doi: 10.1093/gbe/evw066.

10.

Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci.

Devine VT, Jefferies JM, Clarke SC, Faust SN.

J Immunol Res. 2015;2015:394368. doi: 10.1155/2015/394368. Epub 2015 Aug 16. Review.

11.

Vaccine preventable meningitis in Malaysia: epidemiology and management.

McNeil HC, Jefferies JM, Clarke SC.

Expert Rev Anti Infect Ther. 2015 Jun;13(6):705-14. doi: 10.1586/14787210.2015.1033401. Review.

PMID:
25962101
12.

Current methods for capsular typing of Streptococcus pneumoniae.

Jauneikaite E, Tocheva AS, Jefferies JM, Gladstone RA, Faust SN, Christodoulides M, Hibberd ML, Clarke SC.

J Microbiol Methods. 2015 Jun;113:41-9. doi: 10.1016/j.mimet.2015.03.006. Epub 2015 Mar 25. Review.

PMID:
25819558
13.

Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction.

Gladstone RA, Jefferies JM, Tocheva AS, Beard KR, Garley D, Chong WW, Bentley SD, Faust SN, Clarke SC.

Vaccine. 2015 Apr 21;33(17):2015-21. doi: 10.1016/j.vaccine.2015.03.012. Epub 2015 Mar 14.

14.

Evaluation of swabbing methods for estimating the prevalence of bacterial carriage in the upper respiratory tract: a cross sectional study.

Coughtrie AL, Whittaker RN, Begum N, Anderson R, Tuck A, Faust SN, Jefferies JM, Yuen HM, Roderick PJ, Mullee MA, Moore MV, Clarke SC.

BMJ Open. 2014 Oct 30;4(10):e005341. doi: 10.1136/bmjopen-2014-005341.

15.

Lifestyle risk factors for invasive pneumococcal disease: a systematic review.

Cruickshank HC, Jefferies JM, Clarke SC.

BMJ Open. 2014 Jun 20;4(6):e005224. doi: 10.1136/bmjopen-2014-005224. Review.

16.

Novel clones of Streptococcus pneumoniae causing invasive disease in Malaysia.

Jefferies JM, Mohd Yusof MY, Devi Sekaran S, Clarke SC.

PLoS One. 2014 Jun 18;9(6):e97912. doi: 10.1371/journal.pone.0097912. eCollection 2014.

17.

Trends in serotypes and sequence types among cases of invasive pneumococcal disease in Scotland, 1999-2010.

Lamb KE, Flasche S, Diggle M, Inverarity D, Greenhalgh D, Jefferies JM, Smith A, Edwards GF, Denham B, McMenamin J, McDonald E, Mitchell TJ, Clarke SC, Robertson C.

Vaccine. 2014 Jul 23;32(34):4356-63. doi: 10.1016/j.vaccine.2013.05.079. Epub 2013 Jun 24.

18.

Clonal expansion within pneumococcal serotype 6C after use of seven-valent vaccine.

Loman NJ, Gladstone RA, Constantinidou C, Tocheva AS, Jefferies JM, Faust SN, O'Connor L, Chan J, Pallen MJ, Clarke SC.

PLoS One. 2013 May 28;8(5):e64731. doi: 10.1371/journal.pone.0064731. Print 2013.

19.

Distribution of carried pneumococcal clones in UK children following the introduction of the 7-valent pneumococcal conjugate vaccine: a 3-year cross-sectional population based analysis.

Tocheva AS, Jefferies JM, Christodoulides M, Faust SN, Clarke SC.

Vaccine. 2013 Jun 28;31(31):3187-90. doi: 10.1016/j.vaccine.2013.04.075. Epub 2013 May 13.

PMID:
23680442
20.

Nasal self-swabbing for estimating the prevalence of Staphylococcus aureus in the community.

Gamblin J, Jefferies JM, Harris S, Ahmad N, Marsh P, Faust SN, Fraser S, Moore M, Roderick P, Blair I, Clarke SC.

J Med Microbiol. 2013 Mar;62(Pt 3):437-40. doi: 10.1099/jmm.0.051854-0. Epub 2012 Dec 6.

PMID:
23222858
21.

Pneumococcal 13-valent conjugate vaccine for the prevention of invasive pneumococcal disease in children and adults.

Gladstone RA, Jefferies JM, Faust SN, Clarke SC.

Expert Rev Vaccines. 2012 Aug;11(8):889-902.

PMID:
23002969
22.

Sampling methods for the study of pneumococcal carriage: a systematic review.

Gladstone RA, Jefferies JM, Faust SN, Clarke SC.

Vaccine. 2012 Nov 6;30(48):6738-44. doi: 10.1016/j.vaccine.2012.08.080. Epub 2012 Sep 12. Review.

PMID:
22981760
23.

The epidemiology of pneumococcal carriage and infections in Malaysia.

Le CF, Jefferies JM, Yusof MY, Sekaran SD, Clarke SC.

Expert Rev Anti Infect Ther. 2012 Jun;10(6):707-19. doi: 10.1586/eri.12.54. Review.

PMID:
22734960
24.

Pseudomonas aeruginosa outbreaks in the neonatal intensive care unit--a systematic review of risk factors and environmental sources.

Jefferies JM, Cooper T, Yam T, Clarke SC.

J Med Microbiol. 2012 Aug;61(Pt 8):1052-61. doi: 10.1099/jmm.0.044818-0. Epub 2012 Jun 8. Review.

PMID:
22683659
25.

Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: a review.

Jauneikaite E, Jefferies JM, Hibberd ML, Clarke SC.

Vaccine. 2012 May 21;30(24):3503-14. doi: 10.1016/j.vaccine.2012.03.066. Epub 2012 Apr 1. Review.

PMID:
22475858
26.

13-valent pneumococcal conjugate vaccine (PCV13).

Jefferies JM, Macdonald E, Faust SN, Clarke SC.

Hum Vaccin. 2011 Oct;7(10):1012-8. doi: 10.4161/hv.7.10.16794. Epub 2011 Oct 1. Review.

PMID:
21941097
27.

Risk of red queen dynamics in pneumococcal vaccine strategy.

Jefferies JM, Clarke SC, Webb JS, Kraaijeveld AR.

Trends Microbiol. 2011 Aug;19(8):377-81. doi: 10.1016/j.tim.2011.06.001. Epub 2011 Jul 15.

PMID:
21763141
28.

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.

Tocheva AS, Jefferies JM, Rubery H, Bennett J, Afimeke G, Garland J, Christodoulides M, Faust SN, Clarke SC.

Vaccine. 2011 Jun 10;29(26):4400-4. doi: 10.1016/j.vaccine.2011.04.004. Epub 2011 Apr 17.

PMID:
21504773
29.

Death or survival from invasive pneumococcal disease in Scotland: associations with serogroups and multilocus sequence types.

Inverarity D, Lamb K, Diggle M, Robertson C, Greenhalgh D, Mitchell TJ, Smith A, Jefferies JM, Clarke SC, McMenamin J, Edwards GF.

J Med Microbiol. 2011 Jun;60(Pt 6):793-802. doi: 10.1099/jmm.0.028803-0. Epub 2011 Mar 10.

30.

Molecular analysis of Streptococcus pneumoniae clones causing invasive disease in children in Singapore.

Jefferies JM, Tee WS, Clarke SC.

J Med Microbiol. 2011 Jun;60(Pt 6):750-5. doi: 10.1099/jmm.0.030007-0. Epub 2011 Feb 17.

PMID:
21330410
31.

Continued control of pneumococcal disease in the UK - the impact of vaccination.

Gladstone RA, Jefferies JM, Faust SN, Clarke SC.

J Med Microbiol. 2011 Jan;60(Pt 1):1-8. doi: 10.1099/jmm.0.020016-0. Epub 2010 Oct 21. Review.

PMID:
20965923
32.

Characterization of community and hospital Staphylococcus aureus isolates in Southampton, UK.

Green SM, Marsh P, Ahmad N, Jefferies JM, Clarke SC.

J Med Microbiol. 2010 Sep;59(Pt 9):1084-8. doi: 10.1099/jmm.0.018986-0. Epub 2010 Jun 10.

PMID:
20538891
33.

Identification of novel pneumolysin alleles from paediatric carriage isolates of Streptococcus pneumoniae.

Jefferies JM, Tocheva AS, Rubery H, Bennett J, Garland J, Christodoulides M, Faust SN, Smith A, Mitchell TJ, Clarke SC.

J Med Microbiol. 2010 Jul;59(Pt 7):808-14. doi: 10.1099/jmm.0.018663-0. Epub 2010 Mar 25.

PMID:
20339017
34.

Increase in serotype 6C pneumococcal carriage, United Kingdom.

Tocheva AS, Jefferies JM, Christodoulides M, Faust SN, Clarke SC.

Emerg Infect Dis. 2010 Jan;16(1):154-5. doi: 10.3201/eid1601.090650. No abstract available.

35.

Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.

Jefferies JM, Smith AJ, Edwards GF, McMenamin J, Mitchell TJ, Clarke SC.

J Clin Microbiol. 2010 Jan;48(1):87-96. doi: 10.1128/JCM.01485-09. Epub 2009 Nov 18.

36.

PclA, a pneumococcal collagen-like protein with selected strain distribution, contributes to adherence and invasion of host cells.

Paterson GK, Nieminen L, Jefferies JM, Mitchell TJ.

FEMS Microbiol Lett. 2008 Aug;285(2):170-6. doi: 10.1111/j.1574-6968.2008.01217.x. Epub 2008 Jun 28.

37.

Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks.

Jefferies JM, Johnston CH, Kirkham LA, Cowan GJ, Ross KS, Smith A, Clarke SC, Brueggemann AB, George RC, Pichon B, Pluschke G, Pfluger V, Mitchell TJ.

J Infect Dis. 2007 Sep 15;196(6):936-44. Epub 2007 Aug 6.

PMID:
17703426
38.

Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland.

Clarke SC, Jefferies JM, Smith AJ, McMenamin J, Mitchell TJ, Edwards GF.

J Med Microbiol. 2006 Aug;55(Pt 8):1079-84.

PMID:
16849728
39.

Genomic diversity between strains of the same serotype and multilocus sequence type among pneumococcal clinical isolates.

Silva NA, McCluskey J, Jefferies JM, Hinds J, Smith A, Clarke SC, Mitchell TJ, Paterson GK.

Infect Immun. 2006 Jun;74(6):3513-8.

40.

Automation of MLST using third-generation liquid-handling technology.

Sullivan CB, Jefferies JM, Diggle MA, Clarke SC.

Mol Biotechnol. 2006 Mar;32(3):219-26.

PMID:
16632888
41.

Potential impact of conjugate vaccine on the incidence of invasive pneumococcal disease among children in Scotland.

Clarke SC, Jefferies JM, Smith AJ, McMenamin J, Mitchell TJ, Edwards GF.

J Clin Microbiol. 2006 Apr;44(4):1224-8.

42.

Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Kirkham LA, Jefferies JM, Kerr AR, Jing Y, Clarke SC, Smith A, Mitchell TJ.

J Clin Microbiol. 2006 Jan;44(1):151-9.

43.

Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching.

Jefferies JM, Smith A, Clarke SC, Dowson C, Mitchell TJ.

J Clin Microbiol. 2004 Dec;42(12):5681-8.

Supplemental Content

Loading ...
Support Center